Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Learn about the key financial habits for success that can pave the way to wealth. Start building these habits today!
26,788 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A sharp divergence in the online brokerage space emerges in 2026 as Robinhood declines while Interactive Brokers gain...
Canaccord Genuity boosts its price target on Plug Power to $4, citing early wins from Project Quantum Leap. The firm ...
AI projects are stalling in many firms despite heavy investment, prompting Fortune’s Workplace Innovation Summit to p...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...
Nvidia's surge in AI chips is reshaping markets, and some analysts frame it as a $200 billion warning for rivals like...
Uber is dialing back its push on wide AI bets, choosing measured investments aimed at ROI and platform reliability. T...
The space-launch landscape is shifting as Blue Origin faces a setback. This could paradoxically amplify SpaceX's IPO ...
Three AI powerhouses eye the public markets. This guide breaks down how to compare SpaceX, Anthropic, and OpenAI IPOs...
MIT economist and public thinker Daron Acemoglu argues AI's productivity gains will be modest in the near term, while...
Two Senate bills would let six-story apartment buildings use a single interior exit stair, a move that could lower co...
Tesla accelerates margin gains in Q1 2026 as Rivian pushes its R2 strategy through partnerships and new products, hig...